- Home
- CRIS vs RKDA Comparison
CRIS vs RKDA Comparison
Compare CRIS & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | RKDA |
|---|---|---|
| Founded | 2000 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 976.1K | 1.1M |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRIS | RKDA |
|---|---|---|
| Price | $0.66 | $0.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $42.67 | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 540.7K |
| Earning Date | 11-12-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | 66.92 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | $4,858,000.00 |
| Revenue This Year | N/A | $58.50 |
| Revenue Next Year | N/A | $475.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.33 | $0.11 |
| 52 Week High | $2,880.00 | $7.74 |
Technical Indicators
Market Signals| Indicator | CRIS | RKDA |
|---|---|---|
| Relative Strength Index (RSI) | 32.31 | 28.20 |
| Support Level | $0.33 | $0.13 |
| Resistance Level | $5.55 | $0.18 |
| Average True Range (ATR) | 0.21 | 0.02 |
| MACD | 0.32 | 0.02 |
| Stochastic Oscillator | 23.39 | 62.23 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.